Evolution of the Average Target: Humana Inc.

Evolution of the Target Price: Humana Inc.

Changes in Analyst Recommendations: Humana Inc.

92e302b37a771ada8.0Nw5Gk4N-bIoeF5KTwbz3Mixj6rh-Z0l7l9V_bFLkGE.opIMQxZDwflkPBcaKkO9g7yA7vmSrMITuBJtlcE5oTOmshRwOVyTwR1VFw~f812710eedd4f55dd1be91eba16b88ff
Barclays Adjusts Price Target on Humana to $268 From $273 12/06 MT
Jefferies Adjusts Price Target on Humana to $244 From $287 11/06 MT
Wolfe Research Adjusts Price Target on Humana to $283 From $339, Maintains Outperform Rating 06/06 MT
Barclays Adjusts Price Target on Humana to $273 From $322, Maintains Equalweight Rating 02/06 MT
Deutsche Bank Adjusts Humana Price Target to $262 From $260 02/05 MT
Jefferies Adjusts Price Target on Humana to $287 From $241 01/05 MT
Leerink Adjusts Price Target on Humana to $271 From $282 01/05 MT
Oppenheimer Adjusts Price Target on Humana to $310 From $300, Maintains Outperform Rating 01/05 MT
Raymond James Upgrades Humana to Outperform From Market Perform, Price Target is $315 01/05 MT
Baird Adjusts Price Target on Humana to $300 From $270, Maintains Neutral Rating 15/04 MT
Morgan Stanley Adjusts Price Target on Humana to $290 From $285, Maintains Equalweight Rating 15/04 MT
Truist Securities Raises Price Target on Humana to $325 From $290, Hold Rating Maintained 11/04 MT
Guggenheim Initiates Humana at Buy With $326 Price Target 09/04 MT
Wolfe Research Adjusts Price Target on Humana to $339 From $333, Maintains Outperform Rating 28/03 MT
UBS Adjusts Price Target on Humana to $285 From $250, Keeps Neutral Rating 24/02 MT
Bernstein Adjusts Humana Price Target to $313 From $322 19/02 MT
JPMorgan Adjusts Price Target on Humana to $256 From $257, Maintains Neutral Rating 18/02 MT
Jefferies Adjusts Price Target on Humana to $241 From $253, Maintains Hold Rating 12/02 MT
Barclays Adjusts Price Target on Humana to $270 From $255, Keeps Equalweight Rating 12/02 MT
Leerink Partners Adjusts Price Target on Humana to $282 From $280, Maintains Market Perform Rating 12/02 MT
Morgan Stanley Adjusts Price Target on Humana to $285 From $301, Keeps Equalweight Rating 12/02 MT
Morgan Stanley Lowers Price Target on Humana to $285 From $301, Keeps Equalweight Rating 12/02 MT
Deutsche Bank Adjusts Humana Price Target to $260 From $265, Maintains Hold Rating 12/02 MT
Wolfe Research Adjusts Humana Price Target to $333 From $342, Maintains Outperform Rating 27/01 MT
Barclays Adjusts Price Target on Humana to $255 From $253, Maintains Equalweight Rating 22/01 MT
More recommendations

Consensus (Composite) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Ecart obj. / dr
+26.89%
+22.9%
+30.22%
+18.25%
+38.54%
+20.58%
+21.97%
+24.82%
+62.48%
+28.26%
Average +29.49%
Weighted average by Cap. +24.41%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
235.26USD
Average target price
298.53USD
Spread / Average Target
+26.89%
High Price Target
402.23USD
Spread / Highest target
+70.97%
Low Price Target
244.00USD
Spread / Lowest Target
+3.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barclays
Jefferies & Co.
Wolfe Research
Deutsche Bank Securities
Leerink Partners
Oppenheimer
Raymond James
Baird
Morgan Stanley
Truist Securities
Guggenheim
UBS
Bernstein
JPMorgan Chase
Piper Sandler
Wells Fargo Securities
Nephron Research
Cantor Fitzgerald
RBC Capital Markets
Stephens Inc.
Mizuho Securities
KeyBanc Capital Markets
TD Cowen
BofA Securities
Goldman Sachs
Zacks Investment Research
Argus
SVB Securities LLC
Cowen
Credit Suisse
Loop Capital
BMO Capital
SVB Leerink
Citigroup
Seaport Global Securities
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Consensus Humana Inc.